(Q45882286)

17 December 2017

title

A hypoxia-inducible vigilant vector system for activating therapeutic genes in ischemia (English)

1 reference

17 December 2017

0 references

Y L Tang

1

1 reference

17 December 2017

Y Tang

2

1 reference

17 December 2017

Y C Zhang

3

1 reference

17 December 2017

A Agarwal

4

1 reference

17 December 2017

H Kasahara

5

1 reference

17 December 2017

K Qian

6

1 reference

17 December 2017

L Shen

7

1 reference

17 December 2017

M I Phillips

8

1 reference

17 December 2017

publication date

1 August 2005

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

12

1 reference

17 December 2017

issue

15

1 reference

17 December 2017

page(s)

1163-1170

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302513

exact match

0 references

cites work

A role for hypoxia and hypoxia-inducible transcription factors in tumor physiology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302513

Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302513

VEGF gene delivery to myocardium: deleterious effects of unregulated expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302513

Hypoxia-mediated tumour targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302513

Novel chimeric gene promoters responsive to hypoxia and ionizing radiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302513

Adeno-associated viral vector-mediated hypoxia response element-regulated gene expression in mouse ischemic heart model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302513

Characterization of physiologically regulated vectors for the treatment of ischemic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302513

An adenoviral vector regulated by hypoxia for the treatment of ischaemic disease and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302513

A hypoxia-regulated adeno-associated virus vector for cancer-specific gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302513

Hypoxia-regulated transgene expression in experimental retinal and choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302513

Long-term reversal of chronic anemia using a hypoxia-regulated erythropoietin gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302513

Regulated expression of a foreign gene targeted to the ischaemic myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302513

Hypoxia inducible double plasmid system for myocardial ischemia gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302513

Vigilant vector: heart-specific promoter in an adeno-associated virus vector for cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302513

Hypoxia-regulated therapeutic gene as a preemptive treatment strategy against ischemia/reperfusion tissue injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302513

Vigilant vectors: adeno-associated virus with a biosensor to switch on amplified therapeutic genes in specific tissues in life-threatening diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302513

HIF-1 and mechanisms of hypoxia sensing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302513

Accumulation of HIF-1alpha under the influence of nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302513

Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302513

Hypoxia-inducible factor 1alpha protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302513

A regulatory system for use in gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302513

Positional specification of ventricular myosin light chain 2 expression in the primitive murine heart tube

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302513

Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302513

Protection from ischemic heart injury by a vigilant heme oxygenase-1 plasmid system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302513

A new dual-vector approach to enhance recombinant adeno-associated virus-mediated gene expression through intermolecular cis activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302513

Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302513

Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302513

Regulation of gene expression in vivo following transduction by two separate rAAV vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302513

Hypoxia, HIF-1, and the pathophysiology of common human diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302513

7 January 2021

VEGF gene delivery to muscle: potential role for vasculogenesis in adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302513

7 January 2021

HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302513

7 January 2021

Cardioselective overexpression of HO-1 prevents I/R-induced cardiac dysfunction and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302513

7 January 2021

Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302513

7 January 2021

Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302513

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302513

1 reference

17 December 2017

Dimensions Publication ID

1000571225

0 references

Fatcat ID

release_xhosy6f2fjaofb4wxbjcrfsuh4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xhosy6f2fjaofb4wxbjcrfsuh4

24 November 2022

mapped directly with Wikidata item

1 reference

17 December 2017